Literature DB >> 20678178

Early prosthetic joint infection: outcomes with debridement and implant retention followed by antibiotic therapy.

J Cobo1, L Garcia San Miguel, G Euba, D Rodríguez, J M García-Lechuz, M Riera, L Falgueras, J Palomino, N Benito, M D del Toro, C Pigrau, J Ariza.   

Abstract

Recent expert reviews recommend a conservative surgical strategy - debridement and irrigation, antibiotics and implant retention (DAIR) - for most early post-surgical prosthetic joint infections (PJI). However, differences exist in published series regarding success rates with DAIR, and the size of most series is small. In this prospective multicenter cohort study of early PJI managed by DAIR, factors associated with failure of the DAIR were analyzed. Out of 139 early PJI, 117 cases managed with DAIR were studied For 67 patients (57.3%), infection was cured and the implant was salvaged with definite antimicrobial therapy. In 35 (29.9%) DAIR failed and removal of the prosthesis was necessary during follow-up. Finally, 15 patients (12.8%) needed chronic suppressive antimicrobial therapy due to suspected or confirmed persistent infection. Infections due to methicillin-resistant S. aureus (72.7% failed; p 0.05) and those treated at one of the hospitals (80.0% failed; p <0.05) had worse outcomes, but only this last variable was associated with treatment failure following multivariate analysis. Seventy-four per cent of patients who were successfully treated by DAIR and only 32.7% of the failures were able to walk without help or with one stick at the last follow-up visit (p <0.05). In conclusion, a substantial proportion of patients with an early PJI may be successfully treated with DAIR and definite antimicrobial therapy. In more than half of these, the infection can be cured. Since identification of factors associated with failure of DAIR is not simple, we recommend offering DAIR to most patients with early PJI.
© 2011 The Authors. Clinical Microbiology and Infection © 2011 European Society of Clinical Microbiology and Infectious Diseases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20678178     DOI: 10.1111/j.1469-0691.2010.03333.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  38 in total

Review 1.  [Periprosthetic infections of the hip joint : Clinical approach].

Authors:  H M L Mühlhofer; H Gollwitzer; F Lenze; S Feihl; F Pohlig; R von Eisenhart-Rothe; J Schauwecker
Journal:  Orthopade       Date:  2015-05       Impact factor: 1.087

2.  What is the Long-term Economic Societal Effect of Periprosthetic Infections After THA? A Markov Analysis.

Authors:  Thomas J Parisi; Joseph F Konopka; Hany S Bedair
Journal:  Clin Orthop Relat Res       Date:  2017-04-07       Impact factor: 4.176

Review 3.  Low-Virulence Organisms and Periprosthetic Joint Infection-Biofilm Considerations of These Organisms.

Authors:  K Keely Boyle; Stuart Wood; T David Tarity
Journal:  Curr Rev Musculoskelet Med       Date:  2018-09

4.  Platelet-rich plasma lysate displays antibiofilm properties and restores antimicrobial activity against synovial fluid biofilms in vitro.

Authors:  Jessica M Gilbertie; Thomas P Schaer; Alicia G Schubert; Megan E Jacob; Stefano Menegatti; R Ashton Lavoie; Lauren V Schnabel
Journal:  J Orthop Res       Date:  2020-01-14       Impact factor: 3.494

Review 5.  Treatment of acute periprosthetic infections with prosthesis retention: Review of current concepts.

Authors:  Jesse Wp Kuiper; Robin Tjeenk Willink; Dirk Jan F Moojen; Michel Pj van den Bekerom; Sascha Colen
Journal:  World J Orthop       Date:  2014-11-18

6.  Aggressive early débridement for treatment of acutely infected cemented total hip arthroplasty.

Authors:  Mohamed Sukeik; Shelain Patel; Fares Sami Haddad
Journal:  Clin Orthop Relat Res       Date:  2012-11       Impact factor: 4.176

7.  Increased risk of joint failure in hip prostheses infected with Staphylococcus aureus treated with debridement, antibiotics and implant retention compared to Streptococcus.

Authors:  Michael Betz; Sophie Abrassart; Pierre Vaudaux; Ergys Gjika; Maximilian Schindler; Julien Billières; Besa Zenelaj; Domizio Suvà; Robin Peter; Ilker Uçkay
Journal:  Int Orthop       Date:  2014-09-04       Impact factor: 3.075

8.  Antibiotic release from F-doped nanotubular oxide layer on TI6AL4V alloy to decrease bacterial viability.

Authors:  John-Jairo Aguilera-Correa; Antonio L Doadrio; Ana Conde; Maria-Angeles Arenas; Juan-Jose de-Damborenea; María Vallet-Regí; Jaime Esteban
Journal:  J Mater Sci Mater Med       Date:  2018-07-20       Impact factor: 3.896

Review 9.  Can periprosthetic hip joint infections be successfully managed by debridement and prosthesis retention?

Authors:  Konstantinos Anagnostakos; Cornelia Schmitt
Journal:  World J Orthop       Date:  2014-07-18

Review 10.  Pathogen-driven decision for implant retention in the management of infected total knee prostheses.

Authors:  Line Zürcher-Pfund; Ilker Uçkay; Laurence Legout; Axel Gamulin; Pierre Vaudaux; Robin Peter
Journal:  Int Orthop       Date:  2013-05-22       Impact factor: 3.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.